Quick Takeaways
- Kaupinen Wes filed SCHEDULE 13D for PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value per share (PVLA).
- Disclosed ownership: 15%.
- Date of event: 13 Dec 2024.
Kaupinen Wes - 13 Dec 2024 SCHEDULE 13D Report for PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value per share (PVLA)
- Filing Manager
- Kaupinen Wes
- Reporting Manager
- Kaupinen Wes
- Symbol
- PVLA
- Shares outstanding
- 11,266,226 shares
- Disclosed Ownership
- 1,644,869 shares
- Ownership
- 15%
- Form type
- SCHEDULE 13D
- Filing time
- 20 Dec 2024, 17:32:09 UTC
- Date of event
- 13 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Kaupinen Wes disclosed 15% ownership in PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value per share (PVLA) on 13 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 20 Dec 2024, 17:32.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (5)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Kaupinen Wes | 15% | 1,644,869 | 82,051 | 1,562,818 | Wesley H. Kaupinen | Wesley H. Kaupinen | 0001918142 |
| Wesley H. Kaupinen 2019 Irrevocable Trust dated February 28, 2019 | 6.9% | 781,409 | 0 | 781,409 | Christine L. Kaupinen | Trustee | |
| Christine L. Kaupinen | 14% | 1,562,818 | 0 | 1,562,818 | Christine L. Kaupinen | Christine L. Kaupinen | |
| Christine L. Kaupinen 2019 Irrevocable Trust dated February 28, 2019 | 6.9% | 781,409 | 0 | 781,409 | Michael Christopher | Trustee | |
| Michael Christopher | 6.9% | 781,409 | 0 | 781,409 | Michael Christopher | Michael Christopher |